Evidence-aware
Safety focused
Women’s Health Clinic FAQ
Can the O-Shot help leaking during exercise?
Leaking during exercise is often stress-type leakage, but the right pathway depends on triggers, severity, pelvic-floor strength, childbirth history, menopause, prolapse symptoms, and whether urgency is also present. The O-Shot may be discussed for selected cases.
Direct answer
Leaking during exercise is often stress-type leakage, but the right pathway depends on triggers, severity, pelvic-floor strength, childbirth history, menopause, prolapse symptoms, and whether urgency is also present. The O-Shot may be discussed for selected cases.
The most useful plan starts with the underlying cause, not the treatment name. Your clinician should review symptoms, medical history, alternatives, expected benefits, limitations and safety.
Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.
At a glance
These are the main points to understand before deciding whether this option is suitable.
At a glance
Clinical summary
Condition
Leaking urine during exercise, coughing, or sneezing is known as Stress Urinary Incontinence (SUI).
Treatment (O-Shot)
The O-Shot utilizes Platelet-Rich Plasma (PRP) derived from your own blood.
Mechanism
PRP releases growth factors that stimulate collagen synthesis, new blood vessel formation, and tissue regeneration.
Goal
By injecting PRP into the anterior vaginal wall and periurethral area, the treatment aims to provide better support.
Important safety note
Safety Profile: Because the O-Shot uses autologous blood (your own blood), the risk of allergic reactions, foreign body rejection, or severe immunological complications is low.
Suitability
Evidence
Safety
Aftercare
Detailed answer
Detailed answer
Efficacy Rates: Multiple prospective studies show symptom improvement in 50% to 80% of women treated for SUI with PRP. Single vs. Multiple Doses: A 2024 randomised controlled trial showed a single PRP injection was not more effective than a placebo, highlighting that multiple injections are likely required.
Clinical context
Efficacy Rates: Multiple prospective studies show symptom improvement in 50% to 80% of women treated for SUI with PRP.
Evidence
Symptoms
Alternatives
What it means
Efficacy Rates: Multiple prospective studies show symptom improvement in 50% to 80% of women treated for SUI with PRP.
Why it happens
Single vs.
Evidence limits
Synergy with Exercise: Outcomes are improved when PRP is combined with Pelvic Floor Muscle Training (PFMT) compared to PFMT alone.
Treatment fit
Comparison to Surgery: While synthetic mid-urethral slings offer higher objective cure rates (e. g.
What this means in practice
Costs should be confirmed on the /pricing/ page before booking
Procedure Time: The entire process takes approximately 30 to 60 minutes in an outpatient setting. Onset of Results: Initial improvements may be noticed within a few weeks, but peak reported response usually take 3 to 4 months to fully develop.
Patient safety
Why proper assessment matters
Assessment helps separate marketing claims from safe, individualised clinical decision-making.
It checks the cause
Efficacy Rates: Multiple prospective studies show symptom improvement in 50% to 80% of women treated for SUI with PRP.
It protects safety
Safety Profile: Because the O-Shot uses autologous blood (your own blood), the risk of allergic reactions, foreign body rejection, or severe immunological complications is low.
It reviews alternatives
Costs should be confirmed on the /pricing/ page before booking
It sets expectations
Procedure Time: The entire process takes approximately 30 to 60 minutes in an outpatient setting.
A clinical decision, not a shortcut
The safest final page should explain what the intervention may do, what it cannot promise, and when another route may be better.
Treatment should be discussed with realistic goals, informed consent, clear aftercare and a plan for review.
Considerations
What to consider
Costs should be confirmed on the /pricing/ page before booking
Consultation priorities
Consultation: Evaluation of medical history, SUI severity, and ruling out other forms of incontinence (like severe urge incontinence).
Consent
Aftercare
Follow-up
Before treatment
Consultation: Evaluation of medical history, SUI severity, and ruling out other forms of incontinence (like severe urge incontinence).
During care
Preparation: A small sample of blood (10-20 mL) is drawn from your arm and spun in a specialised centrifuge to isolate the platelet-rich plasma.
Aftercare
Injection Phase: Topical numbing cream or local anaesthetic is applied to the vaginal and periurethral tissues.
When to reassess
Aftercare: Immediate return to daily activities. Patients may be advised to briefly abstain from sexual intercourse or using tampons for a few days to optimise healing.
Practical expectations
Procedure Time: The entire process takes approximately 30 to 60 minutes in an outpatient setting.
Setting: Performed in a clinic or doctor's office, not an operating theatre.
Common concerns and myths
Common misconceptions
Clear patient information should correct over-simple claims and keep expectations realistic.
Myth: Exercise leakage is simply poor fitness.
Reality: suitability depends on the symptom pattern, medical history, contraindications, alternatives and individual goals.
Myth: Stopping exercise is the only answer.
Reality: results vary, evidence may be developing, and non-response should prompt reassessment.
Myth: PRP alone replaces pelvic-floor rehabilitation.
Reality: injections, devices and intimate procedures can still carry risks and need proper consent and aftercare.
Evidence and advertising
Single vs.
Alternatives
Costs should be confirmed on the /pricing/ page before booking
Safety checklist
Safety checklist
Use these questions to decide whether treatment should be discussed, delayed or redirected.
Has the cause been assessed?
Symptoms should be reviewed in context before selecting a treatment.
Are red flags absent?
Safety Profile: Because the O-Shot uses autologous blood (your own blood), the risk of allergic reactions, foreign body rejection, or severe immunological complications is low.
Are alternatives clear?
Costs should be confirmed on the /pricing/ page before booking
Is follow-up planned?
The clinic should explain aftercare, review timing and when to seek help.
Reassuring signs
Proceeding is more reasonable when goals are clear, red flags have been checked, and expectations are realistic.
No red flags
Follow-up plan
Reasons to pause
Safety Profile: Because the O-Shot uses autologous blood (your own blood), the risk of allergic reactions, foreign body rejection, or severe immunological complications is low.
Bleeding
Infection
When to escalate
When to seek medical help
Some symptoms should be assessed before any elective intimate treatment. Use NHS 111 online
Severe or worsening pain
Safety Profile: Because the O-Shot uses autologous blood (your own blood), the risk of allergic reactions, foreign body rejection, or severe immunological complications is low.
Bleeding or discharge
Expected Side Effects: Mild spotting, transient injection-site pain, or temporary swelling resolving within a few days.
Infection signs
Red Flags/Contraindications: PRP therapy should be avoided if you have platelet function disorders, active local infections, or severe thrombocytopenia.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain or breathing difficulty.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
More clinical detail
Benchmark positioning
- The strongest page links leakage to real activities, then presents a sensible hierarchy of assessment, pelvic-floor care, and possible PRP discussion.
Clinical reality
- Efficacy Rates: Multiple prospective studies show symptom improvement in 50% to 80% of women treated for SUI with PRP.
- Single vs. Multiple Doses: A 2024 randomised controlled trial showed a single PRP injection was not more effective than a placebo, highlighting that multiple injections are likely required.
- Synergy with Exercise: Outcomes are improved when PRP is combined with Pelvic Floor Muscle Training (PFMT) compared to PFMT alone.
- Comparison to Surgery: While synthetic mid-urethral slings offer higher objective cure rates (e.g., 80% full recovery), they carry surgical risks such as mesh exposure, chronic pain, and voiding dysfunction.
Timeline and expectations
- Procedure Time: The entire process takes approximately 30 to 60 minutes in an outpatient setting.
- Onset of Results: Initial improvements may be noticed within a few weeks, but peak reported response usually take 3 to 4 months to fully develop.
- Duration of Efficacy: Treatment results typically last between 12 and 18 months, with some lasting up to two years.
- Required Sessions: Clinical protocols often recommend a series of 2 to 4 injections spaced roughly one month apart for best reported response, rather than a single injection.
Practical logistics
- Costs should be confirmed on the /pricing/ page before booking
- Setting: Performed in a clinic or doctor's office, not an operating theatre.
- Downtime: There is usually little recovery time; patients can often return to work and normal daily activities immediately.
Research sources
- Jiang et al. , 2021: Therapeutic Efficacy of Urethral Sphincter Injections of Platelet-Rich Plasma for the Treatment of Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency. Int Neurourol J.
- Saraluck et al. , 2024: Autologous platelet rich plasma (A-PRP) combined with pelvic floor muscle training for the treatment of female stress urinary incontinence (SUI): A randomised control clinical trial. Neurourol Urodyn.
- Ashton et al. , 2024: A Single Injection of Platelet-rich Plasma Injection for the Treatment of Stress Urinary Incontinence in Females: A randomised Placebo-controlled Trial. Urology.
- Dankova et al. , 2023: Efficacy and Safety of Platelet-Rich Plasma Injections for the Treatment of Female Sexual Dysfunction and Stress Urinary Incontinence: A Systematic Review. Biomedicines.
Regulatory resources
Authoritative resources
These resources support assessment-led, evidence-aware patient information.
NICE guidance on vaginal laser for urogenital atrophy
NICE is a UK authority for interventional procedure governance and supports cautious language about evidence, consent and audit.
FDA safety communication on vaginal rejuvenation devices
This safety communication is a useful regulatory reference for avoiding over-claiming around sexual enhancement procedures.
RCOG patient information on menopause symptom treatment
RCOG patient information supports assessment-led discussion of vaginal dryness, discomfort and hormone-related symptoms.
Next step
Book a clinical consultation
A consultation can confirm whether this treatment may be suitable, whether another pathway should come first, and what realistic outcomes and aftercare would look like.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 100 imported records. Additional reviewed material included professional society guidance, peer-reviewed clinical papers, evidence reviews, clinical trial records; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. Disclaimer: The information provided in this payload is for educational and informational purposes only and does not constitute medical advice. The O-Shot (PRP therapy) for stress urinary incontinence is considered an off-label or investigational treatment by many regulatory and medical bodies (such as the FDA, AUA, and NICE). Please consult with a qualified urologist, gynaecologist, or healthcare provider to discuss standard-of-care treatments, surgical alternatives, and whether regenerative therapies are appropriate for your specific clinical needs. Results vary. Not a cure.
